AQST: Aquestive Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 220.01
Enterprise Value ($M) 184.99
Book Value ($M) -60.93
Book Value / Share -0.61
Price / Book -3.61
NCAV ($M) -74.00
NCAV / Share -0.74
Price / NCAV -2.97

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.42
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.48
Current Ratio 4.87

Balance Sheet (mrq) ($M)
Current Assets 89.17
Assets 102.23
Liabilities 163.16
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 57.56
Operating Income -30.77
Net Income -44.14
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -35.76
Cash from Investing -0.16
Cash from Financing 83.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 2.90 -52.66
02-13 13G/A Bratton Douglas K 11.10 -0.40
11-14 13G/A Armistice Capital, Llc 2.93 -29.92
11-08 13G BlackRock, Inc. 6.40 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 798,086 2,283,799 34.95
2025-05-13 4,195,509 8,866,537 47.32
2025-05-12 228,214 1,011,825 22.55
2025-05-09 146,827 901,599 16.29

(click for more detail)

Similar Companies
ANIP – ANI Pharmaceuticals, Inc. APGE – Apogee Therapeutics, Inc.
APLT – Applied Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc.


Financial data and stock pages provided by
Fintel.io